Fixing damaged hearts via tissue engineering
The third annual Cardiovascular Tissue Engineering Symposium met on the College of Alabama at Birmingham final month, a gathering of famous physicians and scientists who share the purpose of making new tissues and new information that may stop or restore coronary heart illness and coronary heart assaults. Talks ranged from the cutting-edge translational work of Phillippe Menasche, M.D., Ph.D., professor of thoracic and cardiovascular surgical procedure, Paris Descartes College, to the fundamental biology analysis of Sean Wu, M.D., Ph.D., an affiliate professor of medication, Stanford College Faculty of Drugs. Menasche's work pioneers human remedy with engineered coronary heart tissue. Wu's work opens the door to producing coronary heart chamber-specific cardiomyocytes from human induced pluripotent stem cells, which act equally to embryonic stem cells, having the potential to distinguish into any kind of cell. Menasche has positioned engineered coronary heart tissue derive...